Dr. Jonathan Rubin joined Alcobra in August of 2013 as the Chief Medical Officer. Previously Dr. Rubin worked at Shire Development for over six years serving as Medical Director in Global Medical Affairs supporting multiple products within the ADHD portfolio.
He graduated with a BS from Yale University, an MD from the University of Connecticut, completed a Pediatric Residency at Albert Einstein/Montefiore, completed an Ambulatory Pediatric fellowship at Boston Children's Hospital and received an MBA from Columbia Business School.